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Abstract
Background Pneumonia is an important complication following esophagectomy; however, a wide range of pneumonia incidence
is reported. The lack of one generally accepted definition prevents valid inter-study comparisons. We aimed to simplify and
validate an existing scoring model to define pneumonia following esophagectomy.
Patients and methods The Utrecht Pneumonia Score, comprising of pulmonary radiography findings, leucocyte count, and
temperature, was simplified and internally validated using bootstrapping in the dataset (n=185) in which it was developed.
Subsequently, the intercept and (shrunk) coefficients of the developed multivariable logistic regression model were applied to an
external dataset (n=201)
Results In the revised Uniform Pneumonia Score, points are assigned based on the temperature, the leucocyte, and the findings of
pulmonary radiography. Themodel discriminationwas excellent in the internal validation set and in the external validation set (C-
statistics 0.93 and 0.91, respectively); furthermore, the model calibrated well in both cohorts.
Conclusion The revised Uniform Pneumonia Score (rUPS) can serve as a means to define post-esophagectomy pneumonia.
Utilization of a uniform definition for pneumonia will improve inter-study comparability and improve the evaluations of new
therapeutic strategies to reduce the pneumonia incidence.
Keywords Esophageal carcinoma . Esophagectomy .
Pneumonia
Background
Each year, esophageal cancer is diagnosed in 460,000 people
worldwide.1 Esophagectomy is the corner stone of treatment
for resectable esophageal cancer. However, this complex
procedure2 is associated with a high rate of complications that
need an invasive re-intervention (27–38 %)3
–6 and a high 90-
day mortality rate (approximately 9 %).7 Pulmonary compli-
cations are most frequently observed and significantly in-
crease the intensive care unit readmission rate, the length of
hospital stay, and the mortality rate.8
,9 This stresses the need
for strategies to reduce these complications. However, re-
search in pneumonia following esophagectomy—which is
the most common postoperative pulmonary complication—
is frustrated by the lack of a widely accepted definition that
is easy to apply.
The reporting of pneumonia was investigated in a recent
systematic review of prospective studies conducted between
2004 and 2009 including more than 50 patients undergoing
esophagectomy.10 Pneumonia rates were reported by 56
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studies but defined by 18 studies only, using 16 different def-
initions. The variation across reported pneumonia rates was
large, ranging from 2 to 39%.10 Since the range of pneumonia
incidence is so strongly determined by definition, valid inter-
study of even within-study comparisons cannot be made.
Recently, an objective scoring system to define pneumonia
at the ward following esophagectomy was developed
(Table 1).8 In the Utrecht Pneumonia Score, pneumonia is
defined based on temperature, leucocyte count, and pulmo-
nary radiography findings. The aim of this study was to inter-
nally and externally validate the Utrecht Pneumonia Score as
definition for pneumonia at the ward in patients following
esophagectomy.
Patients and Methods
Approval was obtained from the local medical ethical com-
mittee, and the need for informed consent was waived for this
study. Analysis and reporting were performed in accordance
with the TRIPOD statement.11 For the internal validation, the
original development set of the UPSwas used,8 consisting of a
consecutive cohort of patients that underwent an esophagec-
tomy with gastric conduit reconstruction in the University
Medical Center Utrecht between October 2003 and
March 2011. For the external validation, a cohort of all con-
secutive patients that underwent an esophagectomy in the
Catharina Hospital Eindhoven between January 2008 and
March 2014 was used. Data for both cohorts were extracted
from prospectively acquired databases which contain patient
characteristics and intraoperative and postoperative data.
Model variables had to be collected retrospectively.
Exclusion criteria were presence of pneumonia at the time of
surgery and death before model variables could be measured.
In addition, complete case analysis was performed by exclud-
ing patients with missing values for model variables, as the
amount of missing data was low.
Surgical Procedure and Postoperative Care
Patients underwent either open or minimally invasive trans-
thoracic or transhiatal esophagectomy with or without robot
assistance. Epidural analgesia was administered routinely dur-
ing and following surgery. A gastric conduit reconstruction
was performed with either a cervical or an intrathoracic anas-
tomosis. Bilateral chest tubes were placed at the end of trans-
thoracic surgery. In the cohort that was used to develop the
UPS, a feeding jejunostomy was created in all patients to
bridge the nil-by-mouth period in the first 5 to 7 days after
esophagectomy. In the validation cohort, the same postopera-
tive nutritional regimen was used except for a subset in which
the feasibility and safety of direct oral intake following esoph-
agectomy were investigated.12 All patients were transferred to
the intensive care unit postoperatively. When patients were
respiratory and hemodynamically stable without support or
intensive monitoring, they were transferred to the surgical
ward.
Outcome Definition
Currently, there is no established well-defined gold standard
for diagnosing pneumonia after esophagectomy.10 Therefore,
pneumonia was defined as the clinical decision to treat
suspected pneumonia, similarly to van der Sluis et al..8
Treatment for pneumonia, unless contra-indicated, was pri-
marily by intravenous cefuroxime or ceftriaxone.
Predictors
In accordance with van der Sluis et al.,8 data for the following
three diagnostic determinants of interest were retrospectively
collected from the patients’ charts of the medium care unit or
hospital ward stay: temperature (°C), leukocyte count (×109/
L), and pulmonary radiography findings. Pulmonary radiog-
raphy findings could include both chest X-rays and/or CT
Table 1 Original and revised Uniform Pneumonia Score, a definition for hospital-acquired pneumonia after esophagectomy
Utrecht Pneumonia Score Revised Uniform Pneumonia Score
Diagnostic determinant Range Score Range Score
Temperature [°C] ≥36.1 and ≤38.4 0 ≥36.1 and ≤38.4 0
≥38.5 and ≤38.9 1 ≤36.0 and ≥38.5 1
≥39.0 and ≤36.0 2
Leukocyte count [×109/L] ≥4.0 and ≤11.0 0 ≥4.0 and ≤11.0 0
<4.0 or >11.0 1 <4.0 or >11.0 1
Pulmonary radiography No infiltrate 0 No infiltrate 0
Diffused (or patchy) infiltrate 1 Diffused (or patchy) infiltrate 1
Well-circumscribed infiltrate 2 Well-circumscribed infiltrate 2
A sum score of 2 points or higher, of which at least 1 point is assigned due to infiltrative findings on pulmonary radiography, indicates treatment of
pneumonia
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scans depending on the availability, preferring CT over con-
ventional X-rays when both were available. In patients not
treated for pneumonia, the temperature, leucocyte count, and
pulmonary radiography were collected on the fourth day at the
hospital ward to ensure a sufficient time from ICU discharge.
In this study, the original UPS was simplified: the revised
Uniform Pneumonia Score (rUPS). The same cutoff values
as used by van der Sluis et al. were applied for pulmonary
radiography and leucocyte count (Table 1). In the original
model, 0, 1, or 2 points could be attributed for temperature.
Since the cutoff value for pneumonia is 2 points, with at least 1
point assigned based on pulmonary radiography, it does not
matter if 1 or 2 points are assigned for temperature. Thus, in
the rUPS, 0 or 1 point could be assigned for temperature
(≥36.1 and ≤38.4 °C=0 points and ≤36.0 or ≥38.5 °C=1
point).
Statistical Analysis
Data were analyzed using SPSS for windows, version 22.0
(IBM Corp., Armonk, New York) and R 3.1.2 open-source
software (http://www.R-project.org). All continuous data
were presented as median (25th percentile–75th percentile),
and all categorical data were presented as number
(percentage).
Patient and treatment-related characteristics as well as post-
operative outcomes besides pneumonia were compared be-
tween the development cohort and external cohort to gain
insight in potential differences. Continuous data were com-
pared using the Mann-Whitney U test, and categorical data
were compared using the chi-squared test. Odds ratios (ORs)
along with 95 % confidence intervals (CIs) for each variable
of the revised Uniform Pneumonia Score were calculated in
the development set.
First, the model performance of the rUPS was assessed for
discriminatory ability and calibration in the development set.
The ability to distinguish a patient with the outcome from a
patient without the outcome is indicated by discrimination,
which was assessed by using the concordance (C) statistic.
Calibration refers to the agreement between predicted proba-
bility of pneumonia by the model and the observed probability
and was assessed by visual inspection of calibration plots.
Second, internal validation of the rUPS was performed by
applying bootstrap re-sampling with 200 repetitions in the
development set. The C-statistics of the original model in
the 200 bootstrap samples were averaged, and the optimism
was indicated by the differences between this average C-
statistic and the original C-statistic.13 As such, bootstrapping
allowed for adjustment of the model performance for opti-
mism caused by model overfitting and additionally provided
a uniform shrinkage factor that was used to adjust the original
model coefficients. Third, the same three variables of the
rUPS that were included in the internal validation were used
for external validation, in which the original intercept and
shrunk coefficients after internal validation of the model were




The process of patient selection is shown in Fig. 1. For the
development dataset, 185 patients were included, of who 67
patients (36 %) were treated for pneumonia at the ward. The
external validation dataset finally consisted of 201 patients of
whom 80 patients (40 %) were treated for pneumonia at the
ward.
Patient Characteristics
The patient and treatment-related characteristics of the devel-
opment and validation datasets are presented in Tables 2 and
3. Significant differences between both cohorts included the
higher rate of ASA 1 patients, T3–T4 tumors, N2–N3 tumors,
cervical anastomosis, recurrent nerve injury, lymph nodes
resected, and a longer hospital admission time among patients
in the development set. In the external cohort, the rate of
alcohol use, neoadjuvant chemoradiation, intrathoracic anas-
tomosis, transhiatal surgery, and direct start of oral intake was
significantly higher compared to the development cohort.
Multivariable Regression Model
The multivariable logistic regression model of the simplified
rUPS in the prediction of treatment for pneumonia is
presented in Table 4. A temperature score of 1 was significant-
ly and independently associated with a higher chance of treat-
ment for pneumonia (OR 12.0, p=0.001). A score of 1 for
leucocyte count was significantly and independently associat-
ed with a higher chance of treatment for pneumonia (OR 6.0,
p=0.006). Pulmonary radiography findings were significantly
and independently associated with an increased chance for
pneumonia treatment (1 point: OR 37.4, p=0.000; 2 points:
OR indefinite).
Internal Validation
The rUPS shows an excellent discriminatory ability
and calibration in the development set (Fig. 2a–b), with an
apparent C-statistic of 0.94. Internal validation by
bootstrapping resulted in an adjusted C-statistic of 0.94,
representing hardly any optimism (i.e., 0.004) due to
overfitting. Using the predefined cutoff value (at least 2 points
of which at last 1 has to be assigned for pulmonary
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radiography), the sensitivity was 79 % and the specificity was
97 %. Slight miscalibration was observed in the group of
patients (n=6) with 2 points assigned, based on leucocyte
count and temperature and the group of patients (n=2) with
1 point only, assigned for radiography. The observed proba-
bility of pneumonia treatment was relatively high in these two
groups, while they were not classified as pneumonia by the
revised UPS. Only one patient of the three patients that had
ARDS had this at the moment pneumonia treatment was ini-
tiated, and the pneumonia score was measured.
External Validation
The rUPS shows an excellent discriminatory ability (C-
statistic of 0.91) and calibration in the validation set (Fig. 3a–
b). The sensitivity was 83 %, and the specificity was 95 % for
the predefined cutoff value. The calibration plot showed a low
observed probability of pneumonia treatment in all patient
groups that were classified as not having pneumonia and a
high probability of pneumonia treatment in all patient groups
with a high predicted probability of pneumonia. None of the
two patients with ARDS had this at the moment that the pneu-
monia score was measured.
Discussion
The necessity for a uniform registration and definition of
pneumonia following esophagectomy has become apparent
by the article of Blencowe et al..10 Now, we show that the
revised Uniform Pneumonia Score discriminates pneumonia
from no pneumonia correctly in more than 90 % of cases in
internal and external validation sets with excellent calibration.
This score consists of easy to measure variables: temperature,
leucocyte count, and pulmonary radiography findings.
The main finding of the study by Blencowe et al. was that
the large range in pneumonia definitions (16 different defini-
tions) used by studies resulted in an equally large range of
reported pneumonia rates (2–39 %).10 Among others, this
study resulted in the initiative to standardize outcome
reporting following esophagectomy, recently published as
the International Consensus on Standardization of Data
Co l l ec t i on fo r Comp l i ca t i ons Assoc i a t ed wi th
Esophagectomy.14 However, for reasons not stated, no con-
sensus statement was made regarding pneumonia. For the def-
inition of pneumonia, the reader was referred to the guidelines
of the American Thoracic Society and Infectious Diseases
Society of America.15 In these guidelines, focusing on
ventilator-associated pneumonia (VAP), the main reference
is the clinical pulmonary infection score (CPIS), which has
been extensively investigated for VAP.16
–18 The gold standard
in these studies were postmortem investigation or microbio-
logical results of bronchoalveolar lavage fluids, both not with-
out flaws.16 Also, studies show that the CPIS criteria are not
applicable to specific patient groups, such as trauma
patients.19
,20 For hospital-acquired pneumonia (HAP), no
scoring system was proposed nor investigated. This shows
the need for the present study in which hospital-acquired
pneumonia was investigated.
This study has several strengths. The model was developed
and revised in a prospectively maintained database including a
large cohort in relation to the number of variables studied.
There was no loss to follow-up, and numbers of missing data
were few. The variables used can be easily and objectively
Fig. 1 Patient flow
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measured. In contrast to most studies, the model was internal-
ly and externally validated, confirming the good discrimina-
tion and calibration in an external cohort of patients that
underwent esophagectomy. Notably, there were many signif-
icant differences between the development cohort and
validation cohort, such as the application of neoadjuvant ther-
apy. This did not impact the discriminatory abilities of the
model, emphasizing that it is generally applicable.
The main limitation of the present study was the lack of a
useable gold standard for the diagnosis of pneumonia. This
lack of an objective definition called for a uniform and objec-
tive scoring model to improve inter-study and inter-hospital
comparability, which was the main reason for this study. We
chose to use the clinical decision to treat a suspected pneumo-
nia as gold standard. Though clinical judgment is subjective
and related to experience, this is the only definition in which
all factors are accounted for, by the attending clinician. For
research purpose however, a clearer definition is needed.
Therefore, we aimed to determine what parameters accurately
determined the outcome of this decision-making process. We
show that our scoring model is a good reflection of the clinical
practice, not only within one center but also between different
centers (inter-hospital). van der Sluis et al. recently showed
that the outcome of sputum culture is not relevant, probably
because the sensitivity is insufficient and the results become
available after the decision to treat pneumonia has been
made.8 Bronchoalveolar lavage is considered to be too











Male 141 (76) 168 (80) 0.356a
Female 44 (24) 40 (19)
Age 64 (58–71) 64 (57–70) 0.533b
Tobacco user 95 (51) 111 (55)c 0.474a
Alcohol user 102 (55) 132 (66)c 0.025a
Comorbidity
Cardial 37 (20) 42 (20) 0.327a
Diabetes 26 (14) 23 (11) 0.441a
COPD 23 (12) 32 (15) 0.606a
ASA score
I 47 (25) 24 (12) 0.007b
II 106 (57) 144 (70)
III 31 (17) 39 (19)
IV 1 (<1) 1 (<1)
Body mass index (kg/m2) 25 (23–28) 26 (23–28)c 0.500b
Tumor infiltration c
Complete pathologic response 9 (5) 45 (23) 0.000a
I 36 (19) 44 (22)
II 16 (9) 43 (21)
III 118 (64) 69 (34)
IV 6 (3) 0
Lymph node metastasis
N0 72 (39) 113 (54) 0.000a
N1 51 (28) 52 (25)
N2 41 (22) 22 (11)
N3 21 (11) 3 (5)
Neoadjuvant therapy
None 114 (62) 20 (10) 0.000a
Chemotherapy 63 (34) 20 (10)
Chemoradiotherapy 8 (4) 167 (80)
Radiotherapy 0 1 (<1)
Table showing the baseline data. For continuous variables, data shown
represent median (interquartile range); all other data are presented as
numbers (percentages)
n number, ASA score American Society of Anesthesiologist score
a Two-sided chi-squared test
bMann-Whitney U test
cMissing, tobacco user n= 1, alcohol user n = 2, body mass index n= 4,
depth of tumor infiltration n= 1











Open transhiatal 29 (16) 42 (20) 0.000a
Open transthoracic 11 (6) 1 (1)
Minimally invasive, transhiatal 22 (12) 61 (29)
Minimally invasive, transthoracic 123 (67) 104 (50)
Level of anastomosis
Intrathoracic 1 (1) 63 (30) 0.000a
Cervical 184 (99) 144 (69)
Lymph nodes resected 19 (13–27) 15 (9–23) 0.000b
Early start of oral intake 0 (0) 29 (17) 0.000a
Clinical outcome
Anastomotic leakage 41 (22) 60 (29) 0.132a
ARDS 3 (2) 2 (1) 0.587a
Recurrent laryngeal nerve injury 18 (10) 6 (3) 0.006a
Cardiac arrythmia 23 (12) 34 (16) 0.215a
Chyle leakage 26 (14) 25 (12) 0.537a
Intensive care unit re-admission 34 (18) 46 (22) 0.275a
Hospital admission time 17 (13–25) 13 (10–22) 0.000b
Table showing the characteristics of the surgery performed and clinical
outcome. For continuous variables, data shown represent median (25th
percentile–75th percentile); all other data are numbers (percentages).
There were no missing data
a Two-sided chi-squared test
bMann-Whitney U test
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invasive to use as routine diagnostic. Another interesting
method to create a gold standard would be to create a consen-
sus statement of several experts via a Delphi procedure.21 It
would be interesting to use this for further validation of the
rUPS.
The observed miscalibration using the rUPS in the predic-
tion of treatment for pneumonia was very low, especially in
the external validation study, indicating an excellent model for
determining pneumonia. The miscalibration which was ob-
served mainly existed in patients in the development data set
that scored 1 point for leucocytes and 1 point for temperature
but 0 points for pulmonary radiography. Most probably, pneu-
monia treatment was initiated in these patients before infil-
trates were visible at pulmonary radiography. Perhaps this
was based on an unmeasured other factor, such as coughing,
which was not included in the rUPS since it was considered
to be subjective. Finally, the calculated odds ratio of 37.4 for
pulmonary radiography should be considered a rather unsta-
ble estimation due to the low numbers of false-positive and
false-negative pulmonary radiography test results in this co-
hort, as reflected by the wide 95 % CI ranging from 11.0 to
127.4. However, even the lower bound of the 95 % CI
suggests that the true underlying OR in the population is
likely very high. This supports the requirement of a pulmo-
nary radiography score of ≥1 in the scoring system for
pneumonia.
The incidence of pneumonia in this study as scored by the
UPS is at the high end of the range of pneumonia rates pub-
lished in literature (2–39 %).10 As shown by Blencowe et al.,
the most obvious underlying reason is the different definitions
used in other studies.10 Another study by van der Sluis et al.
showed that adding the requirement of a positive sputum cul-
ture decreased the pneumonia incidence from 36 to 19 %.8 A
relevant outcome of a study in which therapies for pneumonia
are investigated may consist not only of a reduced incidence
but also of a reduced severity of postoperative pneumonia.
Reporting of pneumonia using the rUPS does not include
information on the severity of pneumonia. This can be solved






(95 % confidence interval)
p Value
Temperature
≥36.1 and ≤38.4 45 (29) 112 (71) Reference
≤36.0 and ≥38.5 22 (79) 6 (21) 12.0 (2.8–51.1) 0.001
Leucocytes
≥4.0 and ≤11.0 9 (11) 75 (89) Reference
<4.0 and >11.0 58 (57) 43 (43) 6.0 (1.7–21.6) 0.006
Pulmonary radiography
No infiltrate 13 (10) 113 (90) Reference
Diffuse or patchy infiltrate 31 (86) 5 (14) 37.4 (11.0–127.4) 0.000
Well-circumscribed infiltrate 23 (100) 0 (0) Indefinite 0.000
Table showing independent odds ratios of the components of the revised Uniform Pneumonia Score, calculated
by logistic regression. Values presented are numbers (percentages) and odds ratios (95 % confidence interval)
Fig. 2 Internal validation: a discrimination and b calibration. The predicted
probability of pneumonia is calculated by the sum of the predictive values of
every independent variable multiplied by presence of every variable. The
observed probability of pneumonia is the percentage of patients treated for
pneumonia at the ward at any given point on the x-axis. Sens sensitivity,
Spec specificity, PPV positive predictive value, NPV negative predictive
value, T temperature, L leukocytes, P pulmonary radiography
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by grading the severity of rUPS-defined pneumonia
using the validated revised Clavien-Dindo classification




The rUPS is the first internally and externally validated meth-
od that accurately predicts treatment for pneumonia following
esophagectomy. Because this score proves to represent the
decision-making process of clinicians to treat for pneumonia
on an inter-hospital level, the rUPS can serve as a means to
define post-esophagectomy pneumonia in research. Future
studies and audits reporting postoperative outcomes of esoph-
agectomy are encouraged to provide pneumonia incidences as
defined by this score to improve inter-study and inter-hospital
comparability.
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